
Sumitomo Pharma
Sumitomo Pharma supports and enables the commercialization of treatments to help patients.
Market cap
$3.0b
Enterprise value
$5.1b
Share price
JPY942.00 4506.T
Recent deals
Authorizing premium user...
Sumitomo Pharma supports and enables the commercialization of treatments to help patients.